Respiratory therapy in children;Inhalation et nébulisation chez l'enfant

Archives de Pediatrie

Volumn 9, Issue SUPPL. 3, 2002, Pages 415-421

  David, V ^a,b   Mely L ^a,b   Siret, D ^a,b   Dubus, J C ^a,b  

^a TIMONE HOSPITAL   (France)

^b NONE

Author keywords

Asthma; Child; Respiratory therapy

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; BEMEDREX; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL PLUS IPRATROPIUM BROMIDE; FLUNISOLIDE; FLUTICASONE PROPIONATE; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; OXITROPIUM BROMIDE; PIRBUTEROL ACETATE; PROLAIR; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL XINAFOATE; SPREOR; TERBUTALINE; UNCLASSIFIED DRUG;

ASTHMA; CHILD; DEVICE; DRUG DELIVERY SYSTEM; DRY POWDER; HUMAN; MEDICAL NEBULIZER; METERED DOSE INHALER; POWDER INHALER; RESPIRATORY TRACT DISEASE; REVIEW; RUGBY;

EID: 16744367551     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(02)00153-7     Document Type: Article

References (22)

1. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers
2. Aerosol properties and lung deposition
3. Les techniques d'inhalation dans le traitement de l'asthme
4. Aérosolthérapie dans l'asthme
5. Physical principles underlaying aerosol therapy
6. Therapeutic aerosols. I. Physical and practical considerations
7. Factors influencing lung deposition of inhaled aerosols
8. Determining equivalence of inhaled medications. Workshop report
9. Studies using radiolabeled aerosols in children
10. Standards for bioequivalence of inhaled products
11. Evaluation des médicaments anti-asthmatiques chez l'enfant
12. Anatomy and physiology in delivery: Can we define our targets?
13. Predicted deposition of nonhydroscopic aerosols in the human lung as a function of subject age
14. The influence of age on aerosol deposition in children with cystic fibrosis
15. Lung deposition from the Turbuhaler in children with cystic fibrosis
16. Délivrance des traitements par inhalation
17. Antiasthmatiques inhalés chez l'enfant. Comment s'y retrouver? Comment choisir?
18. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction
19. Modification des gaz propulseurs dans les aérosols-doseurs pressurisés
20. Hydrofluoralkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose
21. Multiple inhalers confuse asthma patients
22. Third international pediatric consensus statement on the management of childhood asthma